Head-to-head · WeighScore
FormBlends vs HealthRX
The verdict
HealthRX takes it — 86.1/100 to 72.7/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FormBlends | HealthRX |
|---|---|---|
| WeighScore | 72.7/100 | 86.1/100 |
| Grade | C | B |
| Scorecard rank | #75 | #8 |
| Semaglutide | $99/mo (compounded) | $189/mo |
| Tirzepatide | $349/mo (compounded) | $349/mo |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #75 · C
Strengths
- Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
- Physician-supervised program with 24/7 care-team access and free shipping over $150
- Extensive free educational content, guides and provider comparisons on-site
Where it loses points
- Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
- $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
- State availability and LegitScript status not published; pharmacy is its own FormScripts brand
Graded #8 · B
Strengths
- LegitScript-certified (#50087439) — a genuine, verifiable trust signal
- Physician-supervised intake with licensed providers
- Both molecules plus a rare oral GLP tablet option
- Transparent flat monthly pricing, no insurance required
Where it loses points
- Compounded semaglutide/tirzepatide is not FDA-approved
- Some tiers are company-stated and the public site is thin
- Brand Ozempic is a steep pass-through (~$1,299)
- State count is not publicly listed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.